FNDC5 and hepatocellular carcinoma: We subcutaneously injected HCC cells with different levels of expression of FNDC5 into mice to further investigate whether the changes in the levels of expression of FNDC5 in HCC cells continued to affect the efficacy of sorafenib in vivo (Figures 7A, –C).